ArticleOncology letters2021

Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.